Tag: treatment for haemophilia B
CSL completes acquisition of novel gene therapy for haemophilia B
CSL Limited has wrapped up the acquisition of uniQure’s etranacogene dezaparvovec, a novel gene therapy for the treatment of haemophilia B.
Under the agreement, CSL...
Featured Article
Beyond insights: How CRM solutions are transforming the manufacturing industry
The global manufacturing sector is witnessing a seismic shift in its automation approach as companies worldwide, big or small, grapple with the ongoing labour shortage and skills gap within the industry.Â
